Also supporting tumor cell heterogeneity, Ithimakin and collaborators observed that luminal tumors presented a subpopulation of HER2+ ALDH+ (Aldehyde dehydrogenase) CSC-like cells at the tumor invasive front. The gene discussed is ERBB2; the disease is neoplasm.